Breaking News

Board Meeting in Progress of Pakistan International Airlines Corporation Limited

Karachi, Pakistan International Airlines Corporation Limited informed Pakistan Stock Exchange that a meeting of the Board of Directors of the Company scheduled to be held on December 30, 2020 at Karachi to consider First Quarter Financial Statements for the period ended March 31, 2018 and 2019 and Third Quarter Financial Statements for the period ended September 30, 2018 and 2019 is in progress.

Pakistan International Airlines Corporation (PIAC) has been converted via Pakistan International Airlines Corporation (Conversion) Act, 2016 (Act No. XV of 2016), dated 19 April 2016 from a statutory corporation to a company governed by the Companies Ordinance, 1984. The new entity is called Pakistan International Airlines Corporation Limited (PIACL).

Through the PIAC (Conversion) Act, 2016, PIACL has succeeded to all the assets, liabilities, duties and obligations of PIAC. Similarly, PIACL is now entitled to the benefits of all notifications, licenses, permissions, sanctions, authorizations, concessions, decrees, international air service authorizations, agreements, orders and benefits issued or granted in favour of PIAC.

All employees of every grade and category of PIAC is hereby assured that they stand transferred by the PIAC (Conversion) Act, 2016 to PIACL with the same designation and on the same terms and conditions as they held in PIAC.

All lenders (foreign and local, fleet and non-fleet) and other creditors of PIAC shall continue to enjoy from PIACL, the same contractual benefits and protections that they enjoyed from PIAC. All guarantees given by the Federal Government to secure PIAC’s obligations will now continue so as to secure the obligations of PIACL.

The shareholders of PIACL shall be deemed without any fresh issuance of shares to own and hold the same number of shares with the same rights and privileges (including as to class, kind, and face value) as they owned and held in PIAC immediately prior to the conversion.

All proceedings of every description and nature whatsoever by or against or relating to PIAC pending on the date of Conversion, in any court, tribunal, or other authority shall be continued, defended, prosecuted and enforced by or against or relating to PIACL in the same manner and to the same extent as they would have been continued, defended, prosecuted and enforced by or against or relating to PIAC, and the same shall not abate, be discontinued, prejudiced or otherwise affected by the conversion.

Check Also

Datacubed Health Launches eClinical Platform App in China, Ensuring Full Compliance and Accessibility

Datacubed Health and AppInChina Forge Strategic Partnership to Launch eClinical Platform in China New York, New York, Sept. 26, 2023 (GLOBE NEWSWIRE) — Datacubed Health, a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, is excited to announce the official launch of its eClinical platform app in China. […]